Milestone Pharmaceuticals Inc. Common Shares
Symbol: MIST (NASDAQ)
1.93
▼ (-5.17%) -0.105
Company Description:
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Key Stats
- Today's Open: $2.03
- Today's High: $2.044
- Today's Low: $1.88
- Today's Volume: 1.78M
- Yesterday Close: $2.03
- Yesterday High: $2.05
- Yesterday Low: $1.93
- Yesterday Volume: 1.86M
- Last Min Volume: 230
- Last Min High: $1.925
- Last Min Low: $1.925
- Last Min VWAP: $1.925
Company Profile
- Name: Milestone Pharmaceuticals Inc. Common Shares
- Website: https://www.milestonepharma.com
- Listed Date: 2019-05-09
- Location: MONTREAL, A8
- Market Status: Active
- CIK Number: 0001408443
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $172.54M
- Round Lot: 100
- Outstanding Shares: 84.99M
- Asset Type: CS
RECENT FILINGS FOR MIST
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | S-8 | View |
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-07-21 | SCHEDULE 13G | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-14 | 8-K | View |
| 2025-07-14 | 424B5 | View |
| 2025-07-11 | 424B5 | View |
| 2025-07-11 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
Latest News on MIST